Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.

Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. JAMA Cardiol. 2021 09 01; 6(9):1032-1041.

View in: PubMed

subject areas

Aged
Aged
Aspirin
Aspirin
Coronary Angiography
Coronary Angiography
Coronary Artery Disease
Coronary Artery Disease
Drug Therapy, Combination
Drug Therapy, Combination
Female
Female
Global Health
Global Health
Humans
Humans
Incidence
Incidence
Male
Male
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Postoperative Care
Postoperative Care
Postoperative Hemorrhage
Postoperative Hemorrhage
Sex Distribution
Sex Distribution
Sex Factors
Sex Factors
Survival Rate
Survival Rate
Withholding Treatment
Withholding Treatment

authors with profiles

Usman Baber